Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,320,102
+$64,392 QoQ
Shares Held
6,407
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#1,200
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EXCALIBUR MANAGEMENT CORP holds $32,863,371 across 10 Drug Manufacturers - General names. AMGN ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,287 | $9,469,779 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,387 | $6,731,729 | |
| 3 | PFE |
Pfizer Inc
|
155,777 | $3,751,110 | |
| 4 | ABBV |
AbbVie Inc.
|
13,505 | $3,398,398 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,349 | $2,697,232 | |
| 6 | AMGN |
Amgen Inc
This page
|
6,407 | $2,320,102 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
34,161 | $1,968,356 | |
| 8 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,320,102 | 6,407 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,255,710 | 6,411 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,098,384 | 6,411 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,808,337 | 6,408 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,788,898 | 6,407 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,996,100 | 6,407 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,669,920 | 6,407 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,064,077 | 6,406 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,988,744 | 6,365 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,809,696 | 6,365 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,836,127 | 6,375 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,713,345 | 6,375 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,404,276 | 6,325 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,526,651 | 6,315 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,658,571 | 6,315 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,423,401 | 6,315 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,536,439 | 6,315 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,539,184 | 6,365 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,431,934 | 6,365 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,351,390 | 6,355 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,549,031 | 6,355 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,581,187 | 6,355 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,438,149 | 6,255 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,589,770 | 6,255 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,475,304 | 6,255 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,268,076 | 6,255 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||